A recent meta-analysis has highlighted the potential benefits of cornelian cherry (Cornus mas L.) supplementation on various cardiometabolic outcomes. Reviewing data from six studies involving 415 participants, researchers found significant reductions in body weight, body mass index, fasting blood glucose, glycated hemoglobin, and HOMA-IR scores with cornelian cherry intake. Additionally, the analysis revealed an increase in high-density lipoprotein cholesterol levels. Sensitivity analyses further indicated improvements in total plasma triglycerides, total cholesterol, low-density lipoprotein cholesterol, and insulin levels, though no significant effects were observed on waist circumference and liver parameters. These findings suggest that cornelian cherry supplementation could be a valuable strategy for managing cardiometabolic risk factors in high-risk individuals.
Home » Cornelian Cherry Supplementation Found to Significantly Improve Cardiometabolic Health, New Meta-Analysis Shows
Cornelian Cherry Supplementation Found to Significantly Improve Cardiometabolic Health, New Meta-Analysis Shows
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Nucleotide-Rich Meals and Uric Acid
September 29, 2026
Cumin Seed Extract and Its Wound-Healing Potential
September 29, 2026
Beetroot Juice and Heart Health After Menopause
September 21, 2026
Puerarin and the Gut–Liver–Brain Axis in Depression
September 21, 2026
Object Recognition Test (ORT): A Versatile Tool for Memory Research in Mice
September 14, 2026
Yeast Protein on Gut Barrier Function and Inflammation
September 14, 2026